{
    "2020-09-07": [
        [
            {
                "time": "",
                "original_text": "资金流跟踪系列二十五：上资金会重复一季度的大幅外流之势吗？",
                "features": {
                    "keywords": [
                        "资金流",
                        "一季度",
                        "大幅外流"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】药明康德(02359-HK)跌3.01%",
                "features": {
                    "keywords": [
                        "异动股",
                        "药明康德",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "芯片股巨震！但板块内这些股票大涨20%",
                "features": {
                    "keywords": [
                        "芯片股",
                        "巨震",
                        "大涨"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "民生证券医药行业周报：关注高景气医疗器械以及低估值板块机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "高景气",
                        "医疗器械",
                        "低估值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "融资客青睐7股，中源协和买入占比高达39.51%",
                "features": {
                    "keywords": [
                        "融资",
                        "中源协和",
                        "买入占比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：关注估值切换带来低估值板块投资机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值切换",
                        "低估值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【港股医药2020年中报总结】上半年CRO一枝独秀，下半年行业全面恢复可期",
                "features": {
                    "keywords": [
                        "港股医药",
                        "CRO",
                        "全面恢复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}